Malignancies in renal transplant recipients

Transplantation Proceedings

Volumn 32, Issue 7, 2000, Pages 1499-1500

  Kasiske, B L ^a,b   Danpanich, E ^a  

^a North Hennepin Community College   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CANCER; CANCER INCIDENCE; CANCER RISK; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPLENECTOMY;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MINNESOTA; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033670674     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01306-3     Document Type: Article

References (3)

1. Opelz G, Henderson R: Lancet 342:1514, 1993
2. Brunner FP, Landais P, Selwood NH: Nephrol Dial Transplant 10 (suppl 1):74, 1995
3. Sheil AG, Disney AP, Mathew TH, et al: Transplant Proc 29:825, 1997